Originally Posted by
Gary A
Pfizer have started mass producing their vaccine which indicates that trial results are going well. Same goes for the Oxford/AstraZeneca vaccine. They have to gather the data and asses it, no easy task in trails that include tens of thousands of people. There also must be enough positive cases within those groups to have reference point.
The earliest we’re going to see any type of vaccine is December this year. As for people under the age of 60 with no long term health issues, we’re about two to three years away from being inoculated. Those most at risk will get it first, then essential workers with age or health risks. Part of me thinks that the majority of the population won’t even be offered it once the most at risk are inoculated, as the sting from the pandemic is gone at that point.
The percentages of deaths and hospitalisations of younger fitter people are so low that it may render inoculation of those groups utterly pointless and basically a waste of resources.